Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Benefit-risk assessment of GLP-1 receptor agonists for obesity: focus on cardiovascular and gastrointestinal effects
Some studies suggest it can enhance fat metabolism, especially when paired with exercise and a calorie-controlled diet
Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy
Take the Assessment A subscription receipt showing what you paid
Understanding what drives cost can help you evaluate whether this approach fits your budget
US$ 23.12
US$ 26.23
US$ 25.00
US$ 20.71
US$ 25.84
US$ 24.82
